Follow
Nandini Verma
Nandini Verma
Principal Investigator, TMC-ACTREC & Asst. Professor, Homi Bhabha National Institute, Mumbai
Verified email at actrec.gov.in - Homepage
Title
Cited by
Cited by
Year
Evaluation of inhibitory activities of plant extracts on production of LPS-stimulated pro-inflammatory mediators in J774 murine macrophages
N Verma, SK Tripathi, D Sahu, HR Das, RH Das
Molecular and cellular biochemistry 336, 127-135, 2010
952010
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis
N Verma, Y Vinik, A Saroha, NU Nair, E Ruppin, G Mills, T Karn, V Dubey, ...
Science advances 6 (34), eaba8968, 2020
932020
PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition
N Verma, O Keinan, M Selitrennik, T Karn, M Filipits, S Lev
Nature communications 6 (1), 6064, 2015
832015
Effect of seeds of Achyranthes aspera on the immune responses and expression of some immune-related genes in carp Catla catla
R Chakrabarti, PK Srivastava, N Verma, JG Sharma
Fish & shellfish immunology 41 (1), 64-69, 2014
822014
Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4–NDRG1 axis
N Verma, AK Müller, C Kothari, E Panayotopoulou, A Kedan, ...
Cancer research 77 (1), 86-99, 2017
692017
Anti-Inflammatory effects of shea butter through inhibition of iNOS, COX-2, and cytokines via the Nf-Kb pathway in LPS-activated J774 macrophage cells
N Verma, R Chakrabarti, RH Das, HK Gautam
Journal of Complementary and Integrative Medicine 9 (1), 1-11, 2012
502012
Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer
SY Shin, AK Müller, N Verma, S Lev, LK Nguyen
PLoS computational biology 14 (6), e1006192, 2018
372018
HER family in cancer progression: From discovery to 2020 and beyond
R Kumar, B George, MR Campbell, N Verma, AM Paul, C Melo-Alvim, ...
Advances in cancer research 147, 109-160, 2020
322020
PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
A Kedan, N Verma, A Saroha, M Shreberk-Shaked, AK Müller, NU Nair, ...
Cell death & disease 9 (10), 985, 2018
292018
Symposium report: breast cancer in India—trends, environmental exposures and clinical implications
JA McDonald, R Rao, M Gibbons, R Janardhanan, S Jaswal, R Mehrotra, ...
Cancer Causes & Control 32 (6), 567-575, 2021
232021
Evaluation of antiinflammatory activity of Dracaena cinnabari Balf. F. resin.
HRDRKG Deepika Gupta, Nandini Verma
Indian J Nat. Prod. Resour. 5, 215-222., 2014
15*2014
iNOS-targeted 10-23 DNAzyme reduces LPS-induced systemic inflammation and mortality in mice
N Verma, SK Tripathi, I Chaudhury, HR Das, RH Das
Shock 33 (5), 493-499, 2010
132010
Silencing of TNF-α receptors coordinately suppresses TNF-α expression through NF-κB activation blockade in THP-1 macrophage
N Verma, I Chaudhury, D Kumar, RH Das
FEBS letters 583 (17), 2968-2974, 2009
102009
9-cis-canthaxanthin exhibits higher pro-apoptotic activity than all-trans-canthaxanthin isomer in THP-1 macrophage cells
V Venugopalan, N Verma, HK Gautam, PP Saradhi, RH Das
Free radical research 43 (2), 100-105, 2009
92009
Fibronectin gene up-regulation by Arnica montana in human macrophages: Validation by real-time polymerase chain reaction assay
M Marzotto, F Arruda-Silva, P Bellavite
Homeopathy 109 (03), 140-145, 2020
82020
Screening of thermophiles from municipal solid waste and their selective antimicrobial profile
V Venugopalan, B Singh, N Verma, P Nahar, TC Bora, RH Das, ...
Curr. Res. Bacteriol 1 (1), 17-22, 2008
62008
Inducible nitric oxide synthase (iNOS) targeted 10-23 DNAzyme reduces lipopolysaccharide (LPS) induced systemic inflammation and mortality in mice
N Verma, SK Tripathi, I Chaudhury, HR Das, RH Das
Shock, 2009
32009
Silencing of TNF‐α receptors coordinately suppresses TNF‐α expression through NF‐κB activation blockade in THP‐1 macrophage
N Verma, I Chaudhury, D Kumar, RH Das
FEBS Letters 583 (17), 2968-2974, 2009
22009
GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition
N Chaudhary, BS Choudhary, S Patra, S Malvankar, A Shivashankar, ...
bioRxiv, 2023.05. 18.541287, 2023
12023
Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4–NDRG1 Axis
N Verma, AK Müller, C Kothari, E Panayotopoulou, A Kedan, ...
Cancer Research 80 (2), 362-362, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20